EPO Patents = 5

Trademarks = 5

Forward Citations = 25

Loading Chart...

3 inventors (with patents filed for the assignee):

Ivan Bergstein (10 out of 19 patents)

Thomas P Cirrito (3 out of 4 patents)

Christopher Brooks (3 out of 4 patents)

10 patents: Sort by Forward Citations

1. 12357700 - Combination therapy method of treating myeloproliferative neoplasms with a diphtheria toxin-human interleukin-3 conjugate in combination with other agents (2025-07-15),

2. 12357678 - Cancer stem cell targeted cancer vaccines (2025-07-15),

3. 12187802 - IL3Ralpha antibodies and uses thereof (2025-01-07),

4. 11672847 - Cancer stem cell targeted cancer vaccines (2023-06-13),

5. 10906979 - IL3Ralpha antibody conjugates and uses thereof (2021-02-02),

6. 10485858 - Cancer stem cell targeted cancer vaccines (2019-11-26),

7. 10316098 - IL3Rα antibody conjugates and uses thereof (2019-06-11),

8. 9873743 - IL3Rα antibody conjugates and uses thereof (2018-01-23),

9. 9518119 - IL3Rα antibody conjugates and uses thereof (2016-12-13),

10. 8163279 - IL3Rα antibody conjugates and uses thereof (2012-04-24),

Stemline Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, acquisition, development, and commercialization of novel oncology therapeutics. The company's pipeline includes several potential treatments for various forms of cancer, with a focus on targeting cancer stem cells. Stemline Therapeutics is dedicated to advancing innovative therapies that have the potential to improve outcomes for cancer patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

10 Patents

#637 in New York, NY

#1,643 in New York

#29,016 in US

#54,350 in the World

New York, NY, United States of America

Stemline Therapeutics, Inc.

Forward Citations = 25

3 inventors:

Ivan Bergstein (10 out of 19 patents)

Thomas P Cirrito (3 out of 4 patents)

Christopher Brooks (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

5 patents (EPO):

Please report any incorrect information to support@idiyas.com